Fractalkine: moving from chemotaxis to neuroprotection.
Ré
Diane Bérangère
DB
Przedborski
Serge
S
D000818:Animals; D002493:Central Nervous System Diseases / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000502:physiology*; D002633:Chemotaxis / Q000502:physiology*; D004195:Disease Models, Animal; D006801:Humans; D008565:Membrane Proteins / Q000502:physiology*; D017628:Microglia / Q000502:physiology; D008954:Models, Biological; D009474:Neurons / Q000502:physiology; D018696:Neuroprotective Agents / Q000627:therapeutic use*
C515538:CX3CL1 protein, human; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; D008565:Membrane Proteins; D018696:Neuroprotective Agents